Login

The Opening Bell marks 25 years of Encavis AG being listed on the stock exchange. 00:10:00

Share On Facebook Share On Twitter

The Chief Executive Officer (CEO) of Encavis AG, Dr Dierk Paskert (61)

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Key Wins and Future Outlook with Justin Hyland and Will Douglas | Justin Hyland, Managing Director, Hyland Financial Planning.
00:10:00
Ian Jamison on Brexit's Impact and Future M&A Trends
00:10:00
Birimian Lithium Project Financing Strategy
00:10:00
"Innovation, Technology, and AI: Strategic Investment Positioning for Capturing Future Growth Opportunities with BBLAM's Industry Experts"
00:10:00
From Chaos to Hope: Johnson's Journey from Hardship to Education
00:10:00
Mineros Resources: Unlocking Growth as an Emerging Mid-Tier Gold Producer in Colombia and Nicaragua
00:10:00
Reunion Gold's Major Discovery in Guyana: Oko West Project Highlights
00:10:00
Inside Simteract: CEO Marcin Jaśkiewicz on Indie Game Development and Business Strategy | Marcin Jaśkiewicz, President, Simteract SA.
00:10:00
We back ambitious founders who actively seek to invest|Deep Nishar,Managing Director and Member of the Management Committee,General Catalyst
00:10:00
Revolutionizing Client Experience: An Interview with Dennis Moseley-Williams | Dennis Moseley-Williams, Certified Expert in the Experience Economy
00:10:00
Embracing the synergy of technology and values to propel towards a sustainable future, as articulated |Robert Itschner, CEO, BKW AG.
00:10:00
Exploring the CEO's insights into LGI Limited's listing journey and future prospects | Dr Jessica North, CEO, Lgi Ltd.

© 2026 Nehu